Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity
Clinical trial NCT01339104 · COMPLETED
Trial details
- NCT number
- NCT01339104
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-08-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.